CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy

Abstract

The 19th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe’s cancer immunotherapy meeting, was the first in-person event organized by CIMT since the beginning of the COVID-19 pandemic. As a hybrid event from May 10–12, the meeting attracted 920 academic and clinical professionals from over 40 countries, who met to discuss the latest advances in cancer immunology and immunotherapy research. This report summarizes the highlights of CIMT2022.

Keywords

• cimt
• cancer immunotherapy
• tumor vaccination
• cellular therapy
• combination therapy
• tumor microenvironment
• checkpoint blockade
• personalized therapy